收费全文 | 19245篇 |
免费 | 1529篇 |
国内免费 | 37篇 |
耳鼻咽喉 | 244篇 |
儿科学 | 435篇 |
妇产科学 | 438篇 |
基础医学 | 2604篇 |
口腔科学 | 416篇 |
临床医学 | 1771篇 |
内科学 | 4175篇 |
皮肤病学 | 395篇 |
神经病学 | 1682篇 |
特种医学 | 784篇 |
外国民族医学 | 5篇 |
外科学 | 3069篇 |
综合类 | 273篇 |
一般理论 | 18篇 |
预防医学 | 1510篇 |
眼科学 | 436篇 |
药学 | 1095篇 |
中国医学 | 11篇 |
肿瘤学 | 1450篇 |
2022年 | 117篇 |
2021年 | 253篇 |
2020年 | 159篇 |
2019年 | 280篇 |
2018年 | 309篇 |
2017年 | 234篇 |
2016年 | 250篇 |
2015年 | 340篇 |
2014年 | 469篇 |
2013年 | 803篇 |
2012年 | 1016篇 |
2011年 | 1143篇 |
2010年 | 590篇 |
2009年 | 560篇 |
2008年 | 1127篇 |
2007年 | 1194篇 |
2006年 | 1123篇 |
2005年 | 1199篇 |
2004年 | 1103篇 |
2003年 | 1075篇 |
2002年 | 1046篇 |
2001年 | 347篇 |
2000年 | 329篇 |
1999年 | 284篇 |
1998年 | 292篇 |
1997年 | 227篇 |
1996年 | 205篇 |
1995年 | 186篇 |
1994年 | 176篇 |
1993年 | 160篇 |
1992年 | 224篇 |
1991年 | 194篇 |
1990年 | 192篇 |
1989年 | 186篇 |
1988年 | 201篇 |
1987年 | 177篇 |
1986年 | 159篇 |
1985年 | 158篇 |
1984年 | 169篇 |
1983年 | 155篇 |
1982年 | 146篇 |
1981年 | 157篇 |
1980年 | 150篇 |
1979年 | 131篇 |
1978年 | 120篇 |
1977年 | 115篇 |
1976年 | 104篇 |
1975年 | 102篇 |
1974年 | 109篇 |
1973年 | 119篇 |
Background
Early dumping is a poorly defined and incompletely understood complication after Roux-en-Y gastric (RYGB).Objective
We performed a mixed-meal tolerance test in patients after RYGB to address the prevalence of early dumping and to gain further insight into its pathophysiology.Setting
The study was conducted in a regional hospital in the northern part of the Netherlands.Methods
From a random sample of patients who underwent primary RYGB between 2008 and 2011, 46 patients completed the mixed-meal tolerance test. The dumping severity score for early dumping was assessed every 30 minutes. A sum score at 30 or 60 minutes of ≥5 and an incremental score of ≥3 points were defined as indicating a high suspicion of early dumping. Blood samples were collected at baseline, every 10 minutes during the first half hour, and at 60 minutes after the start.Results
The prevalence of a high suspicion of early dumping was 26%. No differences were seen for absolute hematocrit value, inactive glucagon-like peptide-1, and vasoactive intestinal peptide between patients with or without early dumping. Patients at high suspicion of early dumping had higher levels of active glucagon-like peptide-1 and peptide YY.Conclusion
The prevalence of complaints at high suspicion of early dumping in a random population of patients after RYGB is 26% in response to a mixed-meal tolerance test. Postprandial increases in both glucagon-like peptide-1 and peptide YY are associated with symptoms of early dumping, suggesting gut L-cell overactivity in this syndrome. 相似文献Areas covered: This review focuses on current treatments and the future outlook for allergic rhinitis. Pharmacotherapy includes mast cell stabilizers, antihistamines, glucocorticosteroids (GCSs), leukotriene receptor antagonists, and nasal decongestants. Nasal GCSs are currently regarded as the most effective treatment and are considered first-line therapy together with non-sedating antihistamines. The new formulation MP29-02 combines the nasal GCS fluticasone propionate with azelastine in one single spray and has achieved greater improvements than those under monotherapy with modern GCSs or antihistamines. Furthermore, this review discusses allergen immunotherapy alone and in combination with modern monoclonal antibodies.
Expert opinion: Despite the variety of medications for allergic rhinitis, ranging from general symptomatic agents like GCSs or decongestants, to more specific ones like histamine receptor or leukotriene blockers, to causal therapy like immunotherapy, many patients still experience treatment failures or unsatisfactory results. The ultimate goal may be to endotype every downstream pathway separately in order to offer patients individualized, targeted therapy with specific antibodies against the respective pathway. 相似文献